Neuronetics, Inc. (STIM)
$2.97+$0.01 (+0.21%) Today
Jorey Chernett - 10% OwnerJorey Chernett - 10% OwnerJorey Chernett - 10% OwnerJorey Chernett - 10% OwnerJorey Chernett - 10% OwnerJorey Chernett - 10% OwnerNeuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 49,000 | $107K |
| Open-market sale | 1 | 100 | $321 |
| Grant or award | 1 | 500,000 | |
| Other acquisition / disposition | 9 | 115,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
57 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Keith J. Sullivan - Officer | Open-market sale | Common Stock | 8,452 | $1.35 | $11K | |
| Steven Pfanstiel - Officer | Grant or award | Common Stock | 250,000 | $0.00 | - | |
| William Andrew Macan - Officer | Grant or award | Common Stock | 210,000 | $0.00 | - | |
| Keith J. Sullivan - Officer | Open-market sale | Common Stock | 33,847 | $1.65 | $56K | |
| William Andrew Macan - Officer | Open-market sale | Common Stock | 14,120 | $1.65 | $23K | |
| William Andrew Macan - Officer | Open-market sale | Common Stock | 3,485 | $1.55 | $5K | |
| Keith J. Sullivan - Officer | Open-market sale | Common Stock | 40,976 | $1.55 | $64K | |
| William Andrew Macan - Officer | Grant or award | Common Stock | 164,361 | $0.00 | - | |
| Steven Pfanstiel - Officer | Grant or award | Common Stock | 170,212 | $0.00 | - | |
| Glenn P. Muir | Grant or award | Common Stock | 7,554 | $0.00 | - | |
| Sheryl L. Conley | Grant or award | Common Stock | 7,326 | $0.00 | - | |
| Sasha Cucuz | Grant or award | Common Stock | 6,410 | $0.00 | - | |
| Robert Cascella | Grant or award | Common Stock | 10,531 | $0.00 | - | |
| Madryn Asset Management, LP | Open-market sale | Common Stock | 192,806 | $3.72 | $717K | |
| Madryn Asset Management, LP | Open-market sale | Common Stock | 2,925,554 | $3.72 | $10.88M | |
| Madryn Asset Management, LP | Open-market sale | Common Stock | 381,640 | $3.72 | $1.42M | |
| Steven Pfanstiel - Officer | Grant or award | Common Stock | 200,000 | $0.00 | - | |
| Steven Pfanstiel - Officer | Grant or award | Common Stock | 200,000 | $0.00 | - | |
| Glenn P. Muir | Grant or award | Common Stock | 30,000 | - | - | |
| Megan Rosengarten | Grant or award | Common Stock | 30,000 | - | - | |
 Avinash Amin | Grant or award | Common Stock | 30,000 | - | - | |
| Sheryl L. Conley | Grant or award | Common Stock | 30,000 | - | - | |
| Sasha Cucuz | Grant or award | Common Stock | 30,000 | - | - | |
| Robert Cascella | Grant or award | Common Stock | 36,250 | - | - | |
| Stephen Furlong - Officer | Open-market sale | Common Stock | 193,460 | $4.27 | $826K | |
| Stephen Furlong - Officer | Open-market sale | Common Stock | 6,540 | $4.16 | $27K | |
| Stephen Furlong - Officer | Grant or award | Performance Restricted Stock Unit | 150,000 | $0.00 | - | |
| Keith J. Sullivan - Officer | Grant or award | Performance Restricted Stock Unit | 450,000 | $0.00 | - | |
| William Andrew Macan - Officer | Grant or award | Performance Restricted Stock Unit | 135,000 | $0.00 | - | |
| Stephen Furlong - Officer | Open-market sale | Common Stock | 1,368 | $0.82 | $1K | |
| William Andrew Macan - Officer | Open-market sale | Common Stock | 1,541 | $0.82 | $1K |
This is as far as the anonymous view goes. Create a free account for all 57 STIM filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | Former Officer | 149,891 | $464K | View on EDGAR | |
| MACAN WILLIAM ANDREW | Officer | 121,033 | $388K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Neuronetics, Inc. (STIM) had 5 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for STIM runs to 57 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of STIM were filed in the last 90 days, totaling $107K.
1 insider sale of STIM was filed in the last 90 days, totaling $321.
This page tracks STIM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add STIM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
